{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ciclesonide+nasal+aerosol", "query": { "intervention": "ciclesonide nasal aerosol" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 25, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ciclesonide+nasal+aerosol&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-26T06:24:55.092Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00806754", "title": "Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "Ciclesonide nasal spray + placebo Azelastine", "type": "DRUG" }, { "name": "Ciclesonide nasal spray + Azelastine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 340, "start_date": "2006-11", "completion_date": "2007-08", "has_results": false, "last_update_posted_date": "2016-11-23", "last_synced_at": "2026-09-26T06:24:55.092Z", "location_count": 35, "location_summary": "Encinitas, California • Los Angeles, California • Mission Viejo, California + 32 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00806754" }, { "nct_id": "NCT00793858", "title": "A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Allergic Rhinitis" ], "interventions": [ { "name": "placebo, isotonic ciclesonide, hypotonic ciclesonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2009-02", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-06-07", "last_synced_at": "2026-09-26T06:24:55.092Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00793858" }, { "nct_id": "NCT00953147", "title": "A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Allergic Rhinitis", "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "Ciclesonide HFA 80 mcg", "type": "DRUG" }, { "name": "Ciclesonide HFA 160 mcg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1110, "start_date": "2009-08", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2012-06-13", "last_synced_at": "2026-09-26T06:24:55.092Z", "location_count": 45, "location_summary": "Huntington Beach, California • Los Angeles, California • Mission Viejo, California + 36 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palmdale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00953147" }, { "nct_id": "NCT01287364", "title": "Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "ciclesonide hydrofluoroalkane (HFA) nasal aerosol", "type": "DRUG" }, { "name": "mometasone nasal inhalation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 185, "start_date": "2011-02", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-11-02", "last_synced_at": "2026-09-26T06:24:55.092Z", "location_count": 6, "location_summary": "Mission Viejo, California • San Diego, California • North Dartmouth, Massachusetts + 3 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Minneappolis", "state": "Minnesota" }, { "city": "Skillman", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01287364" }, { "nct_id": "NCT01401465", "title": "Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "ciclesonide", "type": "DRUG" }, { "name": "mometasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 327, "start_date": "2011-07", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2013-04-30", "last_synced_at": "2026-09-26T06:24:55.092Z", "location_count": 15, "location_summary": "Huntington Beach, California • Mission Veijo, California • San Diego, California + 11 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Mission Veijo", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01401465" }, { "nct_id": "NCT01550471", "title": "Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma", "Allergic Rhinitis" ], "interventions": [ { "name": "Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo", "type": "DRUG" }, { "name": "Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase", "type": "DRUG" }, { "name": "QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo", "type": "DRUG" }, { "name": "QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris", "type": "DRUG" }, { "name": "Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase", "type": "DRUG" }, { "name": "Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "West Penn Allegheny Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "6 Years to 15 Years" }, "enrollment_count": 22, "start_date": "2012-03", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2020-11-04", "last_synced_at": "2026-09-26T06:24:55.092Z", "location_count": 2, "location_summary": "Green Tree, Pennsylvania • Pittsburgh, Pennsylvania", "locations": [ { "city": "Green Tree", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01550471" }, { "nct_id": "NCT00261287", "title": "Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hay Fever", "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "5 Years", "sex": "ALL", "summary": "2 Years to 5 Years" }, "enrollment_count": 102, "start_date": "2005-11", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2016-11-30", "last_synced_at": "2026-09-26T06:24:55.092Z", "location_count": 3, "location_summary": "Long Beach, California • Normal, Illinois • San Antonio, Texas", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Normal", "state": "Illinois" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00261287" }, { "nct_id": "NCT00163514", "title": "Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis", "Allergic Rhinitis", "Hay Fever" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 636, "start_date": "2004-05", "completion_date": "2005-07", "has_results": false, "last_update_posted_date": "2016-12-02", "last_synced_at": "2026-09-26T06:24:55.092Z", "location_count": 58, "location_summary": "Oxford, Alabama • Huntington Beach, California • Mission Viejo, California + 52 more", "locations": [ { "city": "Oxford", "state": "Alabama" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00163514" }, { "nct_id": "NCT00807053", "title": "Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rhinitis, Allergic, Seasonal" ], "interventions": [ { "name": "Ciclesonide HFA", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 480, "start_date": "2007-04", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2016-12-05", "last_synced_at": "2026-09-26T06:24:55.092Z", "location_count": 31, "location_summary": "Mission Viejo, California • Orange, California • San Diego, California + 28 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00807053" }, { "nct_id": "NCT01654536", "title": "A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "ciclesonide nasal aerosol", "type": "DRUG" }, { "name": "ciclesonide nasal spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 737, "start_date": "2012-09", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2014-07-24", "last_synced_at": "2026-09-26T06:24:55.092Z", "location_count": 31, "location_summary": "Mission Viejo, California • Orange, California • San Diego, California + 26 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01654536" } ] }